Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Association of the C-reactive protein-triglyceride glucose index with all-cause and cardiovascular mortality among U.S. adults with metabolic dysfunction-associated steatotic liver disease: a national cohort study.
Journal: Cardiovascular diabetology
Published: December 28, 2025
Effects of purified eicosapentaenoic acid versus mixed eicosapentaenoic/docosahexaenoic acid pharmacotherapies on coronary plaque volume: network meta-analysis of prospective coronary imaging trials.
Journal: Acta cardiologica
Published: August 12, 2025
Hypertriglyceridemia in cardiac rehabilitation-A residual risk worth targeting?
Journal: International journal of cardiology
Published: July 30, 2025
Effects of Eicosapentaenoic Acid vs Eicosapentaenoic/Docosahexaenoic Acids on Cardiovascular Mortality: Meta-Analysis of Clinical Trials.
Journal: JACC. Advances
Published: February 10, 2025
Estimated glucose disposal rate and the risk of major adverse cardio-cerebrovascular outcomes and mortality in patients undergoing percutaneous coronary intervention: a retrospective cohort study.
Journal: European journal of medical research
Published: February 08, 2025
Atherogenic index of plasma and coronary artery disease: a systematic review and meta-analysis of observational studies.
Journal: Cardiovascular diabetology
Published: November 22, 2024
Time Trends in Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention: Meta-Analysis on Sex Differences.
Journal: JACC. Advances
Published: September 25, 2024
Comparison of product label vs real-world safety data from branded icosapent ethyl users: A select analysis utilizing MarketScan data.
Journal: Journal of clinical lipidology
Published: September 16, 2024
Triglyceride-glucose index as a predictor of cardiac adverse events in acute coronary syndrome patients undergoing percutaneous coronary intervention: role of diabetes.
Journal: BMC cardiovascular disorders
Published: May 15, 2024
Cross-Sectional analysis of demographic and clinical characteristics of patients in the United States using icosapent ethyl.
Journal: Frontiers in cardiovascular medicine
Published: April 02, 2024
Early administration of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis.
Journal: BMC cardiovascular disorders
Published: February 26, 2024
Last Updated: 09/26/2026